Shih-Shin Chang

1.2k total citations
8 papers, 372 citations indexed

About

Shih-Shin Chang is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Shih-Shin Chang has authored 8 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Shih-Shin Chang's work include Viral-associated cancers and disorders (4 papers), Cytomegalovirus and herpesvirus research (3 papers) and Cancer-related Molecular Pathways (2 papers). Shih-Shin Chang is often cited by papers focused on Viral-associated cancers and disorders (4 papers), Cytomegalovirus and herpesvirus research (3 papers) and Cancer-related Molecular Pathways (2 papers). Shih-Shin Chang collaborates with scholars based in Taiwan, Japan and Hong Kong. Shih-Shin Chang's co-authors include Ching-Hwa Tsai, Yao Chang, Chien‐Jen Chen, Horng‐Huei Liou, Kenzo Takada, Miaofen Yen, Ai‐Li Shiau, Mei‐Chi Hsu, Ih‐Jen Su and Man‐Hsin Hung and has published in prestigious journals such as Neurology, Journal of Virology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Shih-Shin Chang

8 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih-Shin Chang Taiwan 7 186 105 88 85 45 8 372
Anastasie Dunn‐Pirio United States 7 100 0.5× 71 0.7× 73 0.8× 26 0.3× 55 1.2× 18 341
Brianne H. Daniels United States 8 55 0.3× 34 0.3× 133 1.5× 132 1.6× 46 1.0× 9 317
Keiji Iwatsuki Japan 8 86 0.5× 47 0.4× 37 0.4× 75 0.9× 54 1.2× 13 300
Mei Mei China 7 63 0.3× 41 0.4× 182 2.1× 113 1.3× 19 0.4× 10 331
J.A.P. Hiel Netherlands 10 52 0.3× 29 0.3× 204 2.3× 35 0.4× 32 0.7× 13 350
Brett S. Marro United States 11 114 0.6× 39 0.4× 153 1.7× 35 0.4× 235 5.2× 17 460
Yawen Zhao China 10 27 0.1× 46 0.4× 135 1.5× 132 1.6× 59 1.3× 45 331
Bernd Kitze Germany 13 62 0.3× 133 1.3× 60 0.7× 24 0.3× 188 4.2× 17 404
A. Wakkach France 9 72 0.4× 194 1.8× 117 1.3× 19 0.2× 85 1.9× 10 409
Cui-Lin Li China 5 137 0.7× 20 0.2× 230 2.6× 21 0.2× 58 1.3× 7 391

Countries citing papers authored by Shih-Shin Chang

Since Specialization
Citations

This map shows the geographic impact of Shih-Shin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih-Shin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih-Shin Chang more than expected).

Fields of papers citing papers by Shih-Shin Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih-Shin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih-Shin Chang. The network helps show where Shih-Shin Chang may publish in the future.

Co-authorship network of co-authors of Shih-Shin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Shih-Shin Chang. A scholar is included among the top collaborators of Shih-Shin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih-Shin Chang. Shih-Shin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Huang, Chao‐Yuan, Feng‐Shu Hsieh, Cheng‐Yi Wang, et al.. (2018). Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response. European Journal of Cancer. 102. 10–22. 62 indexed citations
2.
Huang, Chao‐Yuan, Man‐Hsin Hung, Feng‐Shu Hsieh, et al.. (2018). Antagonizing SET Augments the Effects of Radiation Therapy in Hepatocellular Carcinoma through Reactivation of PP2A-Mediated Akt Downregulation. Journal of Pharmacology and Experimental Therapeutics. 366(3). 410–421. 11 indexed citations
3.
Khotskaya, Yekaterina B., Jia Shen, Shih-Shin Chang, et al.. (2014). Abstract A49: S6K1 promotes invasiveness of breast cancer cells in a novel model of triple-negative breast cancer metastasis. Molecular Cancer Research. 12(11_Supplement). A49–A49. 3 indexed citations
4.
Hsu, Mei‐Chi, Shih-Shin Chang, Ih‐Jen Su, et al.. (2008). Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells. Journal of Virology. 82(7). 3679–3688. 72 indexed citations
5.
Chang, Shih-Shin, Huey‐Huey Chua, Hsin‐Yi Chiu, et al.. (2008). Critical Role of p53 in Histone Deacetylase Inhibitor-Induced Epstein-Barr Virus Zta Expression. Journal of Virology. 82(15). 7745–7751. 31 indexed citations
6.
Yang, Peiwen, et al.. (2008). Effect of phosphorylation on the transactivation activity of Epstein–Barr virus BMRF1, a major target of the viral BGLF4 kinase. Journal of General Virology. 89(4). 884–895. 31 indexed citations
7.
Chang, Yao, Shih-Shin Chang, Heng‐Huan Lee, et al.. (2004). Inhibition of the Epstein–Barr virus lytic cycle by Zta-targeted RNA interference. Journal of General Virology. 85(6). 1371–1379. 41 indexed citations
8.
Chang, Shih-Shin, et al.. (2001). Prevalence, incidence, and mortality of PD. Neurology. 57(9). 1679–1686. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026